1. Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors. (31st December 2023) Authors: Ding, Jian; Guyette, Sarah; Schrand, Brett; Geirut, Jessica; Horton, Holly; Guo, Guangwu; Delgoffe, Greg; Menk, Ashley; Baeuerle, Patrick A.; Hofmeister, Robert; Tighe, Robert Journal: Oncoimmunology Issue: Volume 12:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗